Search for: "MERCK & CO."
Results 1001 - 1020
of 1,266
Sort by Relevance
|
Sort by Date
20 Mar 2008, 8:18 am
And in Eli Lilly & Co. v. [read post]
14 Mar 2008, 6:07 am
Merck & Co., 2003 WL 21658613, at *6 (Ohio App. [read post]
3 Mar 2008, 11:01 am
More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday. [read post]
29 Feb 2008, 8:00 am
., claiming infringement of three patents covering its enlarged-prostate treatment, Avodart; Barr challenges GSK’s Avodart patent: (IP Law360), (GenericsWeb),Fosamax (Alendronate) – Courts in Netherlands and France both invalidate Merck Sharp & Dohme’s European patents for Alendronate: (IP Law360), (The IP Factor), (Generic Pharmaceuticals & IP), Hectorol – Genzyme Corp launches US patent suit against Pentech Pharmaceuticals to… [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics… [read post]
22 Feb 2008, 1:30 pm
The administration is supporting the manufacturer in that case, Warner-Lambert Co. v. [read post]
21 Feb 2008, 10:27 pm
Lawyers will have an extra month to send in paperwork for people who want early payment from a $4.85 billion federal court settlement involving the painkiller Vioxx.February 29th is the deadline for "enrolling" people to get the early payments from Merck & Co., which sold the drug until September 2004. [read post]
15 Feb 2008, 1:49 am
(SGP) and Merck & Co. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle),… [read post]
8 Feb 2008, 1:54 am
However, we soon learned that the drug also caused heart attacks and strokes….information kept from the consuming public.The latest news is that Merck & Co., the drug's manufacturer, has become the subject of a federal grand-jury probe into its sales and marketing practices for Vioxx, the painkiller it pulled from the market in 2004. [read post]
7 Feb 2008, 3:35 pm
Corporate Integrity Agreement Between the Department of Health and Human Services Office of Inspector General and Merck & Co. [read post]
28 Jan 2008, 3:52 am
Merck & Co, Inc., in collaboration with Arena Pharmaceuticals, is taking a patent pending drug into Phase One of a clinical trial (PharmaLive, January 25, 2008). [read post]
25 Jan 2008, 12:12 pm
Here's an excerpt: Merck & Co. and Schering-Plough Corp. defended their actions Friday involving a recently released study that raised questions about... [read post]
21 Jan 2008, 9:41 pm
A recent study prompted The American College of Cardiology to weigh in after a study by Merck & Co. [read post]
17 Jan 2008, 10:00 pm
breaks new ground: (Rouse & Co International), Stopping China online content theft: (China Law Blog),Taking depositions in China: (Part 1 - Experience Not Logic), (Part 2 - Experience Not Logic), (Part 3 - Experience Not Logic).IP re-education a Sisyphean task: (China Hearsay),Patent challenge in China: What's the state of the art? [read post]
17 Jan 2008, 3:51 pm
To date, every plaintiff who has tried a case in state court has dismissed fraudulently joined co-defendants before trial. [read post]
14 Jan 2008, 8:49 am
Long-Awaited Results Of ENHANCE Study Show Zocor + Zetia (= Vytorin) Does Not Improve Patient Outcomes (Posted by Tom Lamb at DrugInjuryWatch.com) A January 14, 2008 Bloomberg article, "Merck, Schering's Vytorin No Better Than Generic (Update 2)", reported the long-awaited results of a study concerning Zetia and Vytorin as well as the immediate fall-out: Merck & Co. and Schering-Plough Corp. said their combination cholesterol drug… [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
10 Jan 2008, 8:06 am
Herrmann discusses the following questions: did Merck's settlement strategy make sense; and, will this settlement buy Merck peace. [read post]
9 Jan 2008, 2:41 pm
Calfee will moderate.A January 7, 2008 post on "The BLT: The Blog of Legal Times" entitled "AEI on Vioxx" provides this same-day report on what was said about Merck's Vioxx Settlement Program by some of the panel members:In November of last year, Merck & Co. negotiated a settlement proposal with plaintiffs attorneys that, if 85 percent of the claimants agree to it, will give $4.85 billion to the thousands of claimants and… [read post]
